Immunosupportive therapies in aging

被引:34
作者
Fueloep, Tamas [1 ]
Larbi, Anis [2 ]
Hirokawa, Katsuiku [3 ]
Mocchegiani, Eugenio [4 ]
Lesourd, Bruno [5 ]
Castle, Stephen [6 ,7 ]
Wikby, Anders [8 ]
Franceschi, Claudio [9 ]
Pawelec, Graham [2 ]
机构
[1] Univ Sherbrooke, Fac Med, Res Ctr Aging, Immunol Program,Geriatr Div, Sherbrooke, PQ J1H 4C4, Canada
[2] Univ Tubingen, Sch Med, Med Res Ctr, Tubingen Ageing & Tumour Immunol Grp, Tubingen, Germany
[3] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol & Immunol Ageing & Dev Sci, Tokyo, Japan
[4] INRCA Ancona, Res Dept, Sect Nutr Immun & Ageing, Immunol Ctr, Ancona, Italy
[5] Hop Univ Clermont Ferrand, Serv Soins Suite, F-63118 Cebazat, France
[6] Univ Calif Los Angeles, VA Greater Los Angeles Healthcare Syst, GRECC, Los Angeles, CA 90073 USA
[7] Univ Calif Los Angeles, Dept Med, Multicampus Div Geriatr & Gerontol, Los Angeles, CA 90073 USA
[8] Jonkoping Univ, Dept Nat Sci & Biomed, Sch Hlth Sci, Jonkoping, Sweden
[9] Univ Bologna, Dept Expt Pathol, Italian Natl Res Ctr Aging, I-40126 Bologna, Italy
关键词
immunosenescence; T cells; phagocytic cells; nutrition; vaccination; exercise; CMV; inflammaging; IRP; immunorestorative therapies;
D O I
10.2147/ciia.2007.2.1.33
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The primary role of the immune system is to protect the organism against pathogens, but age-associated alterations to immunity increase the susceptibility of the elderly to infectious disease. The exact nature of these changes is still controversial, but the use of screening procedures, such as the SENIEUR protocol to exclude underlying illness, helped to better characterize the changes actually related to physiological aging rather than pathology. It is generally agreed that the most marked changes occur in the cellular immune response reflecting profound alterations in T cells. Much of this is due to thymic involution as well as changes in the proportions of T cell subpopulations resulting from antigen exposure, and altered T cell activation pathways. However, a body of data indicates that innate immune responses, including the critical bridge between innate and adaptive immunity, and antigen presenting capacity are not completely resistant to senescence processes. The consequences of all these alterations are an increased incidence of infections, as well as possibly cancers, autoimmune disorders, and chronic inflammatory diseases. The leading question is what, if anything, can we do to prevent these deleterious changes without dangerously dysregulating the precarious balance of productive immunity versus immunopathology? There are many potential new therapeutic means now available to modulate immunosenescence and many others are expected to be available shortly. One main problem in applying these experimental therapies is ethical: there is a common feeling that as ageing is not a disease; the elderly are not sick and therefore do not require adventurous therapies with unpredictable side-effects in mostly frail individuals. Animal models are not helpful in this context. In this chapter we will first briefly review what we think we know about human immunosenescence and its consequences for the health status of elderly individuals. We will then discuss possible interventions that might one day become applicable in an appropriate ethical environment.
引用
收藏
页码:33 / 54
页数:22
相关论文
共 213 条
[1]   Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes [J].
Adorini, L .
IMMUNE MECHANISMS AND DISEASE, 2003, 987 :258-261
[2]   CD27: a memory B-cell marker [J].
Agematsu, K ;
Hokibara, S ;
Nagumo, H ;
Komiyama, A .
IMMUNOLOGY TODAY, 2000, 21 (05) :204-206
[3]  
Ahluwalia N, 2004, J Nutr Health Aging, V8, P2
[4]   Signal transduction in the aging immune system [J].
Akha, AAS ;
Miller, RA .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (05) :486-491
[5]   Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice [J].
Akha, Amir A. Sadighi ;
Berger, Scott B. ;
Miller, Richard A. .
IMMUNOLOGY, 2006, 119 (02) :187-194
[6]   Markers to measure immunomodulation in human nutrition intervention studies [J].
Albers, R ;
Antoine, JM ;
Bourdet-Sicard, R ;
Calder, PC ;
Gleeson, M ;
Lesourd, B ;
Samartín, S ;
Sanderson, IR ;
Van Loo, J ;
Vas Dias, FW ;
Watzl, B .
BRITISH JOURNAL OF NUTRITION, 2005, 94 (03) :452-481
[7]   Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men [J].
Albers, R ;
van der Wielen, RPJ ;
Brink, EJ ;
Hendriks, HFJ ;
Dorovska-Taran, VN ;
Mohede, ICM .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2003, 57 (04) :595-603
[8]   Nutrition and immunity: Laboratory and clinical aspects [J].
Amati, L ;
Cirimele, D ;
Pugliese, V ;
Covelli, V ;
Resta, F ;
Jirillo, E .
CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (24) :1924-1931
[9]   Hormones and immune function: implications of aging [J].
Arlt, W ;
Hewison, M .
AGING CELL, 2004, 3 (04) :209-216
[10]   Aging, immunity, and the varicella-zoster virus [J].
Arvin, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (22) :2266-2267